OliX Pharmaceuticals, Inc., a clinical stage biotechnology company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases. The company's products pipeline includes OLX101 for skin scar; OLX102 for skin whitening; OLX103, an atopic dermatitis product; OLX104 for hair loss; OLX105, an anti-wrinkle product; and OLX106 for diabetic foot ulcer. Its products pipeline also comprise OLX301 for age-related macular degeneration retinal fibrosis; OLX304 for retinitis pigmentosa; OLX201 for lung fibrosis; OLX202 for asthma; OLX203 for influenza; OLX401 for neuropathic pain; OLX701 for liver fibrosis; and OLX701 for cancer immunotherapy. The company has a collaboration agreement with Théa to develop SiRNA therapeutics for ophthalmic diseases; and a research collaboration with PCI Biotech Holding ASA. OliX Pharmaceuticals, Inc. was founded in 2010 and is based in Suwon, South Korea.
OliX PharmaceuticalsInc Dividend Announcement
• OliX PharmaceuticalsInc announced a annually dividend of ₩0.28 per ordinary share which will be made payable on . Ex dividend date: 2022-03-15
• OliX PharmaceuticalsInc's trailing twelve-month (TTM) dividend yield is -%
OliX PharmaceuticalsInc Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2022-03-15 | ₩0.28 | annually |
OliX PharmaceuticalsInc Dividend per year
OliX PharmaceuticalsInc Dividend Yield
OliX PharmaceuticalsInc current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing OliX PharmaceuticalsInc stock? Use our calculator to estimate your expected dividend yield:
OliX PharmaceuticalsInc Financial Ratios
OliX PharmaceuticalsInc Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy OliX PharmaceuticalsInc stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.